Greenwood Capital Associates’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,580	Closed	-$368K	–	246
2024 Q3	$368K	Sell	5,580 -50,235	-90%	-$3.65M	0.05%	203
2024 Q2	$5.16M	Sell	55,815 -29,495	-35%	-$2.61M	0.68%	52
2024 Q1	$8.15M	Sell	85,310 -6,543	-7%	-$550K	1.08%	25
2023 Q4	$7M	Buy	91,853 +1,563	+2%	+$109K	0.91%	39
2023 Q3	$6.26M	Sell	90,290 -21,693	-19%	-$1.74M	0.91%	33
2023 Q2	$10.6M	Buy	111,983 +15,492	+16%	+$1.35M	1.48%	11
2023 Q1	$7.98M	Buy	+96,491	New	+$7.58M	1.15%	27
2018 Q4	–	Sell	-16,155	Closed	-$938K	–	173
2018 Q3	$938K	Buy	16,155 +225	+1%	+$11K	0.2%	79
2018 Q2	$773K	Buy	15,930 +9,081	+133%	+$424K	0.18%	85
2018 Q1	$319K	Buy	6,849 +951	+16%	+$41.3K	0.08%	135
2017 Q4	$222K	Buy	5,898 +39	+0.7%	+$1.43K	0.05%	187
2017 Q3	$213K	Sell	5,859 -93	-2%	-$3.55K	0.05%	184
2017 Q2	$235K	Buy	+5,952	New	+$217K	0.06%	161